↓ Skip to main content

Targeting uPAR by CRISPR/Cas9 System Attenuates Cancer Malignancy and Multidrug Resistance

Overview of attention for article published in Frontiers in oncology, February 2019
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
26 Dimensions

Readers on

mendeley
36 Mendeley